February 7, 2011
Cognigen at ASCPT
Two posters describing pharmacometric analyses completed by scientists from Cognigen Corporation and Sunovion Pharmaceuticals Inc. will be presented at the upcoming American Society for Clinical Pharmacology and Therapeutics annual meeting. The posters are Population Pharmacokinetics of Eslicarbazepine Acetate in Patients With Partial-Onset Seizures and Exposure–Response Analysis of Eslicarbazepine Acetate as Adjunctive Treatment of Patients With Partial-Onset Seizures.
Several Cognigen scientists will attend the ASCPT meeting, which will be held March 2 to 5, 2011, in Dallas, Texas. Leading the Cognigen delegation will be Ted Grasela, president and CEO. Among others attending from Cognigen will be Elizabeth Ludwig, director of clinical pharmacology, and Luann Phillips, director of PK/PD.
